The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

 

Helix Biopharma Corp

TSX: HBP
Delayed quote

$1.80

Today's change+0.20 +12.50%
Updated December 24 12:56 PM EST. Delayed by at least 15 minutes.
 

Helix Biopharma Corp

TSX: HBP
Delayed quote

$1.80

Today's change+0.20 +12.50%
Updated December 24 12:56 PM EST. Delayed by at least 15 minutes.

Helix Biopharma Corp Hits New 20-day High

Helix Biopharma Corp closed up sharply Wednesday, rallying $0.20 or 12.50% to $1.80 and setting a new 20-day high. Over the last five days, shares have gained 12.50% and 25.00% year to date. Shares have outperformed the S&P TSX by 16.93% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.12
Updated December 24 12:56 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q1/2015Q4/2014Q3/2014Q2/2014
Fiscal Quarter Endvalues in $ millions unless otherwise notedOct 31, 201410/31/2014Jul 31, 201407/31/2014Apr 30, 201404/30/2014Jan 31, 201401/31/2014
Revenue0000
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense2223
Selling / general / administrative1111
Research & development1112
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--000
Other operating expenses, total--------
Operating income-2-2-2-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-2-2-2-3
Income after tax-2-2-2-3
Income tax, total--000
Net income-2-2-2-3
Total adjustments to net income--------
Net income before extra. items-2-2-2-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-2-2-2-3
Inc. avail. to common incl. extra. items-2-2-2-3
Diluted net income-2-2-2-3
Dilution adjustment----00
Diluted weighted average shares76737272
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.02-0.03-0.04
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.03-0.02-0.03-0.04